FBT.L vs. BBUS
Compare and contrast key facts about First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and JP Morgan Betabuilders U.S. Equity ETF (BBUS).
FBT.L and BBUS are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBT.L is a passively managed fund by First Trust that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on May 27, 2020. BBUS is a passively managed fund by JPMorgan that tracks the performance of the Morningstar US Target Market Exposure Index. It was launched on Mar 12, 2019. Both FBT.L and BBUS are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
FBT.L vs. BBUS - Performance Comparison
Loading graphics...
FBT.L vs. BBUS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | -1.95% | 17.24% | 7.13% | -0.99% | 3.88% | -2.57% | -2.54% |
BBUS JP Morgan Betabuilders U.S. Equity ETF | -2.46% | 9.38% | 27.08% | 20.84% | -9.88% | 28.33% | 15.74% |
Different Trading Currencies
FBT.L is traded in GBp, while BBUS is traded in USD. To make them comparable, the BBUS values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, FBT.L achieves a -1.95% return, which is significantly higher than BBUS's -2.46% return.
FBT.L
- 1D
- 1.48%
- 1M
- -0.46%
- YTD
- -1.95%
- 6M
- 11.21%
- 1Y
- 17.51%
- 3Y*
- 6.78%
- 5Y*
- 5.26%
- 10Y*
- —
BBUS
- 1D
- 0.50%
- 1M
- -3.22%
- YTD
- -2.46%
- 6M
- -0.36%
- 1Y
- 14.91%
- 3Y*
- 15.79%
- 5Y*
- 12.36%
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBT.L vs. BBUS - Expense Ratio Comparison
FBT.L has a 0.60% expense ratio, which is higher than BBUS's 0.02% expense ratio.
Return for Risk
FBT.L vs. BBUS — Risk / Return Rank
FBT.L
BBUS
FBT.L vs. BBUS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and JP Morgan Betabuilders U.S. Equity ETF (BBUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT.L | BBUS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.82 | 0.80 | +0.02 |
Sortino ratioReturn per unit of downside risk | 1.31 | 1.23 | +0.08 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.19 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | 1.14 | 1.33 | -0.19 |
Martin ratioReturn relative to average drawdown | 2.59 | 5.15 | -2.57 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBT.L | BBUS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.82 | 0.80 | +0.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | 0.78 | -0.44 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.20 | 0.76 | -0.56 |
Correlation
The correlation between FBT.L and BBUS is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
FBT.L vs. BBUS - Dividend Comparison
FBT.L has not paid dividends to shareholders, while BBUS's dividend yield for the trailing twelve months is around 1.13%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBUS JP Morgan Betabuilders U.S. Equity ETF | 1.13% | 1.07% | 1.21% | 1.38% | 1.57% | 1.11% | 1.43% | 1.37% |
Drawdowns
FBT.L vs. BBUS - Drawdown Comparison
The maximum FBT.L drawdown since its inception was -30.39%, which is greater than BBUS's maximum drawdown of -26.89%. Use the drawdown chart below to compare losses from any high point for FBT.L and BBUS.
Loading graphics...
Drawdown Indicators
| FBT.L | BBUS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.39% | -35.35% | +4.96% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -12.12% | -1.69% |
Max Drawdown (5Y)Largest decline over 5 years | -23.70% | -25.46% | +1.76% |
Current DrawdownCurrent decline from peak | -7.94% | -5.86% | -2.08% |
Average DrawdownAverage peak-to-trough decline | -13.73% | -5.57% | -8.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.08% | 2.61% | +3.47% |
Volatility
FBT.L vs. BBUS - Volatility Comparison
First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) has a higher volatility of 7.17% compared to JP Morgan Betabuilders U.S. Equity ETF (BBUS) at 4.58%. This indicates that FBT.L's price experiences larger fluctuations and is considered to be riskier than BBUS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBT.L | BBUS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.17% | 4.58% | +2.59% |
Volatility (6M)Calculated over the trailing 6-month period | 14.82% | 9.48% | +5.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.94% | 18.74% | +3.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.53% | 16.00% | +6.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.00% | 19.08% | +4.92% |